Christy R. Hagan

The University of Kansas Cancer Center — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

22h-index1.8kcitations107works0.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Estrogen and related hormone effects(69), Cytokine Signaling Pathways and Interactions(40), Glycosylation and Glycoproteins Research(12), Cancer Immunotherapy and Biomarkers(8), Endometrial and Cervical Cancer Treatments(7)

Publications107 total

Progesterone receptor-dependent downregulation of MHC class I promotes tumor immune evasion and growth in breast cancer.
UNC Libraries·2025Open Access
Abstract 6543: Progesterone signaling alters the metabolic profile and immune cell landscape of mammary gland tumors
Cancer Research·2025
Progesterone and Estrogen Signaling Impact Each Other’s Transcriptional Activity in Endometrial Cancer
Endocrinology·2025Open Access
Progesterone receptor-dependent downregulation of MHC class I promotes tumor immune evasion and growth in breast cancer
Journal for ImmunoTherapy of Cancer·2025· 3 citedOpen Access
Site-specific O-GlcNAcylation of progesterone receptor (PR) supports PR attenuation of interferon stimulated genes (ISGs) and tumor growth in breast cancer
Journal of Biological Chemistry·2024· 2 citedOpen Access
Abstract 3971: Progesterone impacts regulatory T cell activity to promote immunosuppression in the mammary gland
Cancer Research·2024
Abstract 5364: Progesterone receptor modulates the antigen processing and presentation machinery decreasing MHC class I expression on tumors
Cancer Research·2024
Abstract 3981: Immune targeting progesterone receptor in hormone receptor positive breast cancer
Cancer Research·2024
Abstract 6877: Progesterone promotes immunosuppression in the murine mammary gland by causing T cell death
Cancer Research·2024
Abstract 6571: O-GlcNAc sites on progesterone receptor are critical for its ligand independent repression of interferon signaling in breast cancer
Cancer Research·2024
Abstract B009: Global expression analysis of endometrial cancer cells in response to progesterone identifies new therapeutic targets
Clinical Cancer Research·2024
Global expression analysis of endometrial cancer cells in response to progesterone identifies new therapeutic targets
The Journal of Steroid Biochemistry and Molecular Biology·2023· 2 citedOpen Access
Abstract 5280: O-GlcNAcylation of progesterone receptor promotes mammary tumorigenesis
Cancer Research·2023
Abstract 622: Progesterone promotes immunosuppression in the mammary gland through regulatory T cell activity
Cancer Research·2023
Data from Interferon-Stimulated Genes Are Transcriptionally Repressed by PR in Breast Cancer
2023Open Access
Supplementary data from Interferon-Stimulated Genes Are Transcriptionally Repressed by PR in Breast Cancer
2023Open Access
Data from Interferon-Stimulated Genes Are Transcriptionally Repressed by PR in Breast Cancer
2023Open Access
Supplementary Data from Effect of Bazedoxifene and Conjugated Estrogen (Duavee) on Breast Cancer Risk Biomarkers in High-Risk Women: A Pilot Study
2023Open Access
Supplementary Table from Interferon-Stimulated Genes Are Transcriptionally Repressed by PR in Breast Cancer
2023Open Access
Data from Interaction Between MUC1 and STAT1 Drives IFITM1 Overexpression in Aromatase Inhibitor–Resistant Breast Cancer Cells and Mediates Estrogen-Induced Apoptosis
2023Open Access
page 1 of 6Next →

Frequent Co-authors

Gloria M. Trinca(15), Merit L. Goodman(13), K. Walter(12), Carol A. Lange(11), Prabhakar Chalise(11), Sean M. Holloran(9), Rashna Madan(7), Katelin A. Gibson(7), Ossama Tawfik(7), Mary A. Markiewicz(6), Carol J. Fabian(6), Onalisa Winblad(6), Hanan S. Elsarraj(6), Susan G. Hilsenbeck(6), Dean P. Edwards(6), Andrew K. Godwin(6), Fariba Behbod(6), Gwen E. Dressing(5), Victor X. Jin(5), Andrea R. Daniel(4)